前列腺癌
医学
雄激素受体
肿瘤科
内科学
转移
雄激素剥夺疗法
前列腺
雄激素
阉割
癌症
睾丸切除术
激素
作者
Karim Fizazi,Neal D. Shore,Teuvo L.J. Tammela,Albertas Ulys,Egils Vjaters,S. Polyakov,Mindaugas Jievaltas,Murilo Luz,B. Yа. Alekseev,Iris Kuss,Christian Kappeler,Amir Snapir,Toni Sarapohja,Matthew R. Smith
标识
DOI:10.1056/nejmoa1815671
摘要
Darolutamide is a structurally unique androgen-receptor antagonist that is under development for the treatment of prostate cancer. We evaluated the efficacy of darolutamide for delaying metastasis and death in men with nonmetastatic, castration-resistant prostate cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI